A drug has blocked the brain process that kills cells in incurable Huntington's disease—and works in human cells.

GRAIL is the only company that has applied for MCED FDA premarket approval so far; if approved by the FDA and covered by ...

By Deena Beasley SAN DIEGO, June 23 (Reuters) - U.S. biotechnology industry trade group BIO worked with the Food and Drug ...

By Deena Beasley June 24 (Reuters) - The U.S. Food and Drug Administration, which cut more than 3,000 employees last year, ...

The FDA has accused Pinnacle Biologics of creating videos that make it hard for healthcare professionals to “adequately ...

A first-of-its-kind drug may slow the progression of Huntington's disease, a rare, fatal, neurodegenerative disorder.

The Food and Drug Administration will allow Philip Morris International to market Zyn nicotine pouches as presenting a lower health risk than cigarettes. The decision announced Tuesday authorizes 20 ...

The FDA said on Tuesday it would allow Philip Morris to ​market its Zyn nicotine pouches as less harmful than cigarettes.

Beaumont Occupational Services Offers Certified Drug Testing for Workplaces and Court Requirements Beaumont, United ...

Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor and trapping ...

Kriya Therapeutics, Inc. ("Kriya"), a biotechnology company developing durable medicines for chronic diseases, today announced it has been selected by the U.S. Food and Drug Administration (FDA) to ...

Health officials launch initiative to boost domestic clinical trials and speed new drug development ...